OptiPin
Thymosin Alpha-1: uses, dosing & the facts
An immune-boosting peptide that enhances T-cell function and immune system response. Used for immune support and viral infections. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • Thymosin Alpha-1 — Research peptide. An immune-boosting peptide that enhances T-cell function and immune system response.
- • Commonly used for immune system enhancement, viral infection support, autoimmune disease management.
- • Half-life: Approximately 2 hours.
- • Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.
What Thymosin Alpha-1 is
An immune-boosting peptide that enhances T-cell function and immune system response. Used for immune support and viral infections.
What Thymosin Alpha-1 is used for
- • Immune system enhancement
- • Viral infection support
- • Autoimmune disease management
- • Cancer adjunct therapy
- • Inflammation reduction
- • Covid-19 and flu protection
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Injectable | 1.6-3.2mg twice per week subcutaneously or intramuscularly |
Presented as commonly-reported patterns for information only — not a dose recommendation. Thymosin Alpha-1 dosing is a decision for a qualified clinician.
Reconstitution
Reconstitute 1.6mg vial with 1mL bacteriostatic water. The arithmetic is the same for any peptide: concentration = vial mg ÷ water mL, and on a U-100 syringe 100 units = 1 mL. Compute your own vial with the reconstitution calculator.
Half-life & cycling
Half-life: Approximately 2 hours. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.
Cycling
Can be used continuously for immune support. 6-12 week cycles typical.
Side effects & warnings
- • Generally well-tolerated
- • Mild injection site reactions
- • Rare immune system overstimulation
Powerful immune system modulator. Use with caution in autoimmune conditions. Can significantly boost immune function. Research use only.
Tracking Thymosin Alpha-1 in OptiPin
If you're tracking a Thymosin Alpha-1 protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.
Download on the App StoreFAQ
What is Thymosin Alpha-1?
An immune-boosting peptide that enhances T-cell function and immune system response. Used for immune support and viral infections.
What is Thymosin Alpha-1 used for?
Commonly discussed uses include: immune system enhancement, viral infection support, autoimmune disease management, cancer adjunct therapy, inflammation reduction, covid-19 and flu protection. These are reported uses, not proven outcomes or a recommendation.
How is Thymosin Alpha-1 dosed?
Commonly reported dosing: Injectable — 1.6-3.2mg twice per week subcutaneously or intramuscularly. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — Thymosin Alpha-1 is not an approved medicine and dosing should involve a qualified clinician.
How do you reconstitute Thymosin Alpha-1?
Reconstitute 1.6mg vial with 1mL bacteriostatic water. On a U-100 syringe, 100 units = 1 mL. Concentrations vary by vial, so compute from your own vial with a reconstitution calculator.
What is Thymosin Alpha-1's half-life?
Approximately 2 hours. Half-life shapes how often it is dosed and how quickly it clears.
What are Thymosin Alpha-1's side effects?
Reported effects include: generally well-tolerated, mild injection site reactions, rare immune system overstimulation. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for Thymosin Alpha-1 on PubMed (entry point to the primary evidence base, not a specific citation).
- Thymosin Alpha-1 on ClinicalTrials.gov — registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.
Related
Wolverine · Actovegin · ARA-290 · CJC-1295 (with DAC) · BPC-157 · TB-500 · Reconstitution calculator · All peptides